FTC Chair Andrew Ferguson sent a memo to agency staff on Tuesday clarifying that the Biden-era guidelines will remain in ...

The cuts hit the FDA’s medical device center particularly hard, impacting product reviewers and researchers of AI-enabled medical technology. Notably, the center has a strained relationship with one ...

WASHINGTON — Processed food companies and federal nutrition guidelines and programs could be in the crosshairs of President Donald Trump’s new Make America Healthy Again (MAHA) Commission, according ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...

The progression of evidence has marched forward from studies showing a reduction in salt associated with lower blood pressure ...

About half of U.S. adults have high blood pressure and too few have it under control. Now some patients who've tried ...

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

While the FDA’s diversity guidance for clinical trials has been temporarily restored, the page it is housed on now carries a ...

A core group of so-called disease detectives, who track outbreaks, was apparently spared. But other young researchers are out ...

This finding is especially interesting because the same drug was less effective at lowering blood sugar levels in older ...

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine has found there is no consensus in how clinical experts interpret CGM reports from people without ...

President Donald Trump recently issued two executive orders furthering his policy to reduce the number of federal regulations and the size of ...